
SKYE
Healthcare · Biotechnology · $4.8M market cap
$1.09+0.01 (+0.9%)Nov 13, 4:00 PM EST
Next report
After the close
Analyst consensus
Fiscal period ending Sep 30, 2026
EPS trend, 90 days to now · +44.4% over 90 days · 30-day revisions 0 up, 0 down
Beat estimates in 1 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Nov 16, 2026 · upcoming | After the close | -1.12 | -2.56 | -128.6% |
| Aug 14, 2026 | Before the open | -0.29 | -0.27 | +6.9% |
| May 11, 2026 | After the close | -0.32 | -0.32 | 0.0% |
| Nov 10, 2025 | After the close | -0.32 | -0.32 | 0.0% |
| Aug 7, 2025 | After the close | -0.34 | -0.44 | -29.4% |
| May 8, 2025 | After the close | -0.29 | -0.28 | +3.4% |
| Mar 19, 2025 | After the close | -0.28 | -0.29 | -2.2% |
| Nov 7, 2024 | After the close | -0.25 | -0.10 | +60.0% |
| Aug 9, 2024 | After the close | -0.19 | -0.20 | -5.3% |
| May 10, 2024 | After the close | -0.16 | -0.18 | -12.5% |
| Mar 22, 2024 | Before the open | -0.38 | -0.63 | -65.8% |
| Nov 13, 2023 | After the close | 0.00 | -3.17 | — |
| Aug 7, 2023 | After the close | 0.00 |
Skye Bioscience, Inc., a clinical-stage biotechnology company, develops molecules that modulate G-protein-coupled receptors to treat obesity, overweight, and related metabolic diseases. The company's lead clinical asset is nimacimab, a peripherally-restricted negative allosteric modulating antibody targeting cannabinoid receptor 1 (CB1) administered as a subcutaneous injectable, which targets CB1 receptors in…
| -0.00 |
| — |
| May 31, 2023 | Time not confirmed | — | -0.01 | — |
| Mar 1, 2023 | Time not confirmed | — | -0.01 | — |
| Nov 14, 2022 | Time not confirmed | — | -0.01 | — |
| Aug 15, 2022 | Before the open | — | -0.01 | — |
| Jun 1, 2022 | Time not confirmed | — | -0.01 | — |
| Mar 2, 2022 | Time not confirmed | — | -0.01 | — |
| Dec 1, 2021 | Time not confirmed | — | -0.00 | — |
| Sep 1, 2021 | Time not confirmed | — | -0.01 | — |
| Jun 2, 2021 | Time not confirmed | — | -0.01 | — |
| Mar 3, 2021 | Time not confirmed | — | -0.01 | — |
| Dec 2, 2020 | Time not confirmed | — | -0.01 | — |
| Sep 2, 2020 | Time not confirmed | — | -0.01 | — |
| Jun 3, 2020 | Time not confirmed | — | -0.01 | — |
| Feb 26, 2020 | Time not confirmed | — | 0.03 | — |
| Nov 27, 2019 | Time not confirmed | — | -0.04 | — |
| Aug 28, 2019 | Time not confirmed | — | 0.08 | — |
| May 29, 2019 | Time not confirmed | — | -0.11 | — |
| Feb 27, 2019 | Time not confirmed | — | -0.05 | — |
| Nov 28, 2018 | Time not confirmed | — | -0.02 | — |
| Aug 29, 2018 | Time not confirmed | — | -0.02 | — |
| May 30, 2018 | Time not confirmed | — | -0.09 | — |
| Mar 19, 2018 | After the close | 0.00 | -0.03 | — |